Subscribe
A worldwide window to Cambridge business, innovation and technology
bit.bio clears the way for next phase of growth

bit.bio clears the way for next phase of growth

bit.bio, one of the Cambridge life science cluster’s most exciting companies, has gone through a huge overhaul in the boardroom – including a change of CEO – in a matter of weeks as it bids to underpin long-term prosperity and success.
Orion Corporation to open Biologics R & D centre in Cambridge

Orion Corporation to open Biologics R & D centre in Cambridge

Quoted Finnish pharmaceutical company Orion Corporation is establishing a new research & development centre in Cambridge to accelerate its global growth strategy and the development of innovative medicines.
‘Nuclear’ invention cuts travel time to Mars in half

‘Nuclear’ invention cuts travel time to Mars in half

Pulsar Fusion in Bletchley has brought space propulsion technology out of stealth with the unveiling of Sunbird, a nuclear fusion rocket concept developed in complete secrecy over the past decade.
New crescendo for Harold as she is named T-Therapeutics CEO

New crescendo for Harold as she is named T-Therapeutics CEO

A handful of established Cambridge life science companies have been forced to shed staff – up to CEO level – and close local lab facilities for a variety of reasons.
TRIMTECH raises $31m from Cambridge UK and US backers

TRIMTECH raises $31m from Cambridge UK and US backers

Cambridge biotech TRIMTECH Therapeutics, which is harnessing targeted protein degradation for the treatment of neurodegenerative diseases, has closed an oversubscribed $31 million (£25m) seed round featuring a number of US investors.
Academia
Sharewatch
Manufacturing
Entrepreneurship programme for women launched at Murray Edwards College
12 Mar 2025 - 12:00
Brains in bloom: Sainsbury Laboratory debuts at Chelsea Flower Show
11 Mar 2025 - 12:00
Brain gain milestone as Cambridge Enterprise drives 41 University investments in a year
10 Mar 2025 - 12:00

Business awards

Entries now being accepted

Business directory

Browse our listings of Cambridge companies

The killer 50

The 50 hottest disruptive technology companies

News

Experience at the double as Shift Bioscience scales anti-ageing proposition

Experience at the double as Shift Bioscience scales anti-ageing proposition

Shift Bioscience, a Cambridge biotech using an AI powered virtual cell to fight age-related diseases, has made two shrewd hires as it advances its technology. The company has appointed Jill Reckless as Translation Advisor and Laurence Reid as Non-Executive Director.
Grant Instruments set for further growth after investment coup

Grant Instruments set for further growth after investment coup

Grant Instruments in Royston, which supplies precision temperature control, sample preparation and life-science solutions for global laboratories, is targeting more transatlantic growth following a strategic investment from neighbour Royston Instruments Ltd with funding support from BroadOak Capital Partners.
Employer over-reacted to gender-critical Facebook posts

Employer over-reacted to gender-critical Facebook posts

No employer wants to be on the wrong side of a Court of Appeal ruling. But that’s what has happened recently to a school when it was found to have discriminated against an employee by dismissing her for posting gender critical views on her private Facebook page, writes David Mills, Employment Partner and National Head of Employment law at Mills & Reeve.
Savills lifts revenue and profits despite market vagaries

Savills lifts revenue and profits despite market vagaries

Savills plc has hoisted annual revenue by seven per cent to £2.40 billion in the year to end-December 2024 and sent profits spiralling upwards by 38 per cent to £130.4 million.
More news

Tech trail

Cambridge central to ClariMed’s global expansion strategy

Cambridge central to ClariMed’s global expansion strategy

Strategic acquisitions on both sides of the Atlantic – in Cambridge UK and California US – laid the foundations for global growth for innovative MedTech-focused company ClariMed.
TRIMTECH raises $31m from Cambridge UK and US backers

TRIMTECH raises $31m from Cambridge UK and US backers

Cambridge biotech TRIMTECH Therapeutics, which is harnessing targeted protein degradation for the treatment of neurodegenerative diseases, has closed an oversubscribed $31 million (£25m) seed round featuring a number of US investors.
Cambridge Innovation Capital to curate Start Codon future

Cambridge Innovation Capital to curate Start Codon future

For DeepTech funder Cambridge Innovation Capital, it’s a case of back to the future after its decision to take venture builder Start Codon under its management.
US funders lead $6.9m Seed round for AI drug pioneer Ignota Labs

US funders lead $6.9m Seed round for AI drug pioneer Ignota Labs

Ignota Labs, an AI-driven drug turnaround company which recently moved to Cambridge Science Park, has closed a $6.9 million seed funding round, co-led by Montage Ventures and AIX Ventures in the US with participation from Modi Ventures, Blue Wire Capital and Gaingels.
More Tech trail

Trade floor

42 Technology and partners unveil new AI-powered pharma line clearance solution

42 Technology and partners unveil new AI-powered pharma line clearance solution

42 Technology has joined forces with industry leaders in machine vision, edge AI silicon and software – Balluff, Synaptics and Arcturus Networks – to help develop and demonstrate a breakthrough approach for AI-powered automated line clearance in pharmaceutical manufacturing.
Sunny future tipped for tanning firm after MBO

Sunny future tipped for tanning firm after MBO

A management team has taken over Power Tan Ltd in Bedfordshire to set the stage for further growth and international expansion for the indoor tanning business.
Cambridge triple role in superfast 5G project

Cambridge triple role in superfast 5G project

Cambridge Consultants and city colleagues at Stratospheric Platforms Ltd and Marshall were in a five-firm consortium honoured for their role in ’Project Skymast’, which aims to deliver superfast 5G to every corner of the globe from the stratosphere.
Nxera Pharma clinches millions from autoimmune disease deal

Nxera Pharma clinches millions from autoimmune disease deal

Nxera Pharma, with major operations in Cambridge and Tokyo, has negotiated a lucrative deal in the autoimmune diseases space in Asia-Pacific.
AVEVA and HMEL sign MOU to drive AI-powered digitalisation in India’s refining sector

AVEVA and HMEL sign MOU to drive AI-powered digitalisation in India’s refining sector

Cambridge headquartered AVEVA, a global leader in industrial software, and HPCL Mittal Energy Limited (HMEL) – a leading Indian integrated refining and petrochemical company – have signed a landmark MOU.
More Trade floor